Jump Financial LLC Reduces Stake in Encompass Health Corporation $EHC

Key Points

• Jump Financial LLC has reduced its stake in Encompass Health Corporation by 17.3%, selling 4,695 shares and retaining a total of 22,383 shares valued at approximately $2.27 million.
• Several hedge funds have recently increased or initiated positions in Encompass Health, with institutional investors now owning 97.25% of the company's stock.
• Encompass Health announced a dividend increase to $0.19 per share, up from $0.17, and set its FY 2025 EPS guidance between 5.120-5.340.

Jump Financial LLC reduced its stake in shares of Encompass Health Corporation (NYSE:EHC - Free Report) by 17.3% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 22,383 shares of the company's stock after selling 4,695 shares during the quarter. Jump Financial LLC's holdings in Encompass Health were worth $2,267,000 at the end of the most recent quarter.

Several other institutional investors also recently added to or reduced their stakes in EHC. Colonial Trust Co SC purchased a new stake in Encompass Health in the 4th quarter valued at about $29,000. Mitsubishi UFJ Asset Management Co. Ltd. raised its stake in shares of Encompass Health by 749.0% during the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 416 shares of the company's stock valued at $42,000 after acquiring an additional 367 shares in the last quarter. Arlington Trust Co LLC boosted its holdings in shares of Encompass Health by 22.9% in the first quarter. Arlington Trust Co LLC now owns 671 shares of the company's stock valued at $68,000 after purchasing an additional 125 shares during the period. Johnson Financial Group Inc. bought a new position in Encompass Health in the fourth quarter worth approximately $72,000. Finally, Caitong International Asset Management Co. Ltd increased its holdings in Encompass Health by 19.0% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 720 shares of the company's stock worth $73,000 after purchasing an additional 115 shares during the period. Hedge funds and other institutional investors own 97.25% of the company's stock.

Insider Activity at Encompass Health

In other news, EVP Patrick William Tuer sold 1,020 shares of the business's stock in a transaction on Wednesday, August 27th. The shares were sold at an average price of $123.59, for a total transaction of $126,061.80. Following the sale, the executive vice president directly owned 18,846 shares of the company's stock, valued at $2,329,177.14. The trade was a 5.13% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 2.00% of the company's stock.

Encompass Health Stock Down 1.4%

EHC stock traded down $1.74 on Friday, hitting $121.71. 839,898 shares of the company's stock were exchanged, compared to its average volume of 862,588. The firm has a 50 day moving average price of $116.66 and a two-hundred day moving average price of $111.15. Encompass Health Corporation has a 12-month low of $87.85 and a 12-month high of $124.67. The stock has a market cap of $12.26 billion, a P/E ratio of 23.82, a price-to-earnings-growth ratio of 2.13 and a beta of 0.86. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.06 and a current ratio of 1.06.

Encompass Health (NYSE:EHC - Get Free Report) last issued its quarterly earnings results on Monday, August 4th. The company reported $1.40 earnings per share for the quarter, topping the consensus estimate of $1.20 by $0.20. Encompass Health had a return on equity of 17.83% and a net margin of 9.22%.The business had revenue of $1.46 billion during the quarter, compared to the consensus estimate of $1.43 billion. During the same quarter last year, the company earned $1.11 earnings per share. The company's quarterly revenue was up 12.0% on a year-over-year basis. Encompass Health has set its FY 2025 guidance at 5.120-5.340 EPS. As a group, equities research analysts expect that Encompass Health Corporation will post 4.8 EPS for the current fiscal year.

Encompass Health Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st will be issued a $0.19 dividend. This is an increase from Encompass Health's previous quarterly dividend of $0.17. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend is Wednesday, October 1st. Encompass Health's dividend payout ratio is 13.31%.

Wall Street Analyst Weigh In

Several research firms have recently commented on EHC. UBS Group boosted their price target on shares of Encompass Health from $130.00 to $140.00 and gave the company a "buy" rating in a report on Wednesday, August 6th. Wall Street Zen lowered shares of Encompass Health from a "strong-buy" rating to a "buy" rating in a report on Friday, June 6th. Stephens upgraded Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 target price for the company in a report on Thursday, June 5th. KeyCorp lifted their price target on Encompass Health from $122.00 to $135.00 and gave the company an "overweight" rating in a report on Tuesday, May 27th. Finally, Truist Financial boosted their price target on Encompass Health from $135.00 to $140.00 and gave the stock a "buy" rating in a research report on Thursday, August 14th. One investment analyst has rated the stock with a Strong Buy rating and six have issued a Buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Buy" and a consensus target price of $134.00.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.